WallStSmart

Arch Capital Group Ltd. (ACGL)vsOaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ACGL leads profitability with a 24.4% profit margin vs 0.0%. ACGL trades at a lower P/E of 7.9x. ACGL earns a higher WallStSmart Score of 67/100 (B-).

ACGL

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 8.0Value: 7.0Quality: 6.0
Piotroski: 6/9Altman Z: 1.48

OACC

Avoid

28

out of 100

Grade: F

Growth: 3.7Profit: 3.5Value: 4.7Quality: 5.3
Piotroski: 3/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACGL6 strengths · Avg: 9.2/10
P/E RatioValuation
7.9x10/10

Attractively priced relative to earnings

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Return on EquityProfitability
20.1%9/10

Every $100 of equity generates 20 in profit

Profit MarginProfitability
24.4%9/10

Keeps 24 of every $100 in revenue as profit

Debt/EquityHealth
0.119/10

Conservative balance sheet, low leverage

Operating MarginProfitability
26.6%8/10

Strong operational efficiency at 26.6%

OACC1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

ACGL3 concerns · Avg: 2.0/10
Revenue GrowthGrowth
-10.5%2/10

Revenue declined 10.5%

EPS GrowthGrowth
-7.1%2/10

Earnings declined 7.1%

Altman Z-ScoreHealth
1.482/10

Distress zone — elevated risk

OACC4 concerns · Avg: 3.5/10
P/E RatioValuation
37.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$264.02M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.6%3/10

ROE of 3.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ACGL

The strongest argument for ACGL centers on P/E Ratio, Price/Book, Return on Equity. Profitability is solid with margins at 24.4% and operating margin at 26.6%. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bull Case : OACC

The strongest argument for OACC centers on Debt/Equity.

Bear Case : ACGL

The primary concerns for ACGL are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : OACC

The primary concerns for OACC are P/E Ratio, Revenue Growth, Market Cap.

Key Dynamics to Monitor

ACGL profiles as a declining stock while OACC is a value play — different risk/reward profiles.

OACC is growing revenue faster at 0.0% — sustainability is the question.

ACGL generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ACGL scores higher overall (67/100 vs 28/100), backed by strong 24.4% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arch Capital Group Ltd.

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

Arch Capital Group Ltd., offers insurance, reinsurance and mortgage products worldwide. The company is headquartered in Pembroke, Bermuda.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on identifying and merging with transformative businesses in the life sciences sector, including healthcare technology, therapeutics, and medical devices. Leveraging the expertise of its experienced management team, OACC aims to drive innovation and generate value through strategic acquisitions and partnerships. With a disciplined investment strategy that emphasizes rigorous due diligence, OACC is well-positioned to capitalize on emerging opportunities within the dynamic life sciences market, thereby enhancing shareholder value amidst evolving industry trends.

Visit Website →

Want to dig deeper into these stocks?